Ellis, Ian O.

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

METABRIC Group, Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., et al. (2012) · Nature

Breast Cancer Treatment StudiesCancer Genomics and Diagnostics

Cited by 6,097

Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen

Habashy, H. O., Powe, D. G., Staka, C. M., Rakha, E. A., Ball, G., Green, A. R., Aleskandarany, M., Paish, E. C., Douglas Macmillan, R., Nicholson, R. I., et al. (2010) · Breast Cancer Research and Treatment

Breast Cancer Treatment StudiesEstrogen and related hormone effects

Cited by 236

Lymphatic and blood vessels in basal and triple-negative breast cancers: characteristics and prognostic significance

Mohammed, R. A. A., Ellis, I. O., Mahmmod, A. M., Hawkes, E. C., Green, A. R., Rakha, E. A., & Martin, S. G. (2011) · Modern Pathology

Breast Cancer Treatment StudiesLymphatic System and Diseases

Cited by 145

A randomised trial of primary tamoxifen versus mastectomy plus adjuvant tamoxifen in fit elderly women with invasive breast carcinoma of high oestrogen receptor content: long-term results at 20 years of follow-up

Johnston, S. J., Kenny, F. S., Syed, B. M., Robertson, J. F. R., Pinder, S. E., Winterbottom, L., Ellis, I. O., Blamey, R. W., & Cheung, K. L. (2012) · Annals of Oncology

Breast Cancer Treatment StudiesBreast Lesions and Carcinomas

Cited by 55

HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression Analysis

Abdel-Fatah, T. M. A., McArdle, S. E. B., Agarwal, D., Moseley, P. M., Green, A. R., Ball, G. R., Pockley, A. G., Ellis, I. O., Rees, R. C., & Chan, S. Y. T. (2016) · Clinical Cancer Research

Breast Cancer Treatment StudiesBreast Lesions and Carcinomas

Cited by 20